DOCSLIB.ORG

2019 Final Abstracts Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2019 Final Abstracts Book 19th Internarional Symposium of ISTU 5th European Symposium of EUFUS Barcelona 2019 | 13th - 15th June ABSTRACT BOOK ORGANIZING COMMITEE Scientific Organizing Committee Robin Cleveland, Co-Chair Vera Khokhlova, Co-Chair Local Organizing Committee Joan Vidal-Jové, Chair EUFUS Organizing Committee Andreas Melzer, Co-Chair Wladyslaw Gedroyc Alessandro Napoli Matthias Matzko Lisa Landgraf ISTU Joo Ha Hwang, President Kim Butts Pauly, Secretary General Jean-François Aubry Gail ter Haar Thursday, June 13th 2019 Friday, June 14th 2019 Saturday, June 15th 2019 Education: Getting Medical Education: Neurological Disease Education: Immunology Devices to Market Raúl Martínez Elizabeth Repasky Nicolas Guillen Education: Hyperthermia Welcome Education: Bioeffects of US Technologies Joo Ha Hwang, Joan Vidal-Jové, Diane Dalecki Holger Gruell Andreas Melzer Fry / Lizzi / Pioneer Award Session Horizon / Jolesz Lectures Organ Panel: Brain Invited speakers: Invited speakers: Chairs: Chrit Moonen Invited speakers: Chairs: Jin Woo Chang Chairs: Lawrence Crum Kevin Haworth Morry Blumenfeld Alessandro Napoli Cesare Gagliardo Wladyslaw Gedroyc Jean-François Aubry W. Apoutou N’Djin Neal F. Kassell Wladyslaw Gedroyc Roland Beisteiner Marine Sánchez Joo Ha Hwang Leonid Gavrilov Henning Lohse-Busch Physics and Modelling Drug Delivery Organ Panel: Uterus Invited speakers: Chairs: Invited speakers: Chairs: Invited speakers: Chairs: Jean-François Aubry Bradley Treeby Karun Sharma Holger Grull Suzanne LeBlang Matthias Matzko Robert Staruch Aki Pulkkinen Juan Tu Michael Gray Jaron Rabinovici Nikolaos Bailis Break Break Break Hardware Immunotherapy Organ Panel: Prostate and Kidney Invited speakers: Chairs: Gil Dubernard Amanda Beserra Invited speakers: Chairs: Invited speakers: Chairs: Adam Maxwell Cyril Lafon Elizabeth Repasky Natasha Sheybani Jens Rassweiler Andreas Melzer Chandan Guha Tatiana Khokhlova Mark Emberton George Schade Industry Pitch Lunch & Posters session Lunch & Posters session Lunch break Monitoring and feedback Therapy ultrasound plus Invited speakers: Chairs: Invited speakers: Chairs: Industry Pitch Presentations Henrik Odeen Elodie Cao Sarah Brüningk Gail ter Haar Sunao Shoji Shin-ichiro Umemura Edwin Heijman Lisa Landgraf Nonthermal mechanisms Neuromodulation Organ Panel: Musculoskeletal Invited speakers: Chairs: Invited speakers: Chairs: Invited speakers: Chairs: Francisco Aparisi Markus Duex Tatiana Khokhlova Ki Joo Pahk Elisa Konofagou Lennart Verhagen Pejman Ghanouni Alessandro Napoli Zhen Xu Oleg Sapozhnikov Jan Kubanek Wynn Legon Francesco Arrigoni Alberto Bazzocchi Break Break Break Drug delivery design/engineering Brain – preclinical Organ Panel: Liver and Pancreas Invited speakers: Chairs: Invited speakers: Chairs: Invited speakers: Chairs: John Callan Dario Carugo Richard Price Elisa Konofagou Joo Ha Hwang Joan Vidal-Jové Michel Versluis Eleanor Stride Nathan McDannold Muna Aryal Xavier Serres Milka Marinova Debate – Micron-sized contrast agents Other clinical HIFU applications have a great future in clinical HIFU ISTU General Assembly Invited speakers: Chairs: Andreas Melzer Constantin Coussios Gail ter Haar Joan Vidal-Jové Mike Averkiou Joo Ha Hwang USgHIFU Meeting: Clinical Application EUFUS General Assembly Closing (sponsored session) Joo Ha Hwang, Joan Vidal-Jové, Welcome Reception Gala Dinner Andreas Melzer MRgFUS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS: A CLINICAL UPDATE Raul Martinez Fernandez, Centro Integral en Neurociencias A.C. (HM CINAC), Madrid e-mail: [email protected] Since the first studies using MRgFUS for the treatment of essential tremor came out in 2013, its applications for neurological diseases have progressively increased. Today, MRgFUS thalamotomy is a FDA-approved treatment for both essential and parkinsonian tremors and some evidence suggests that it can also be useful for tremors of other origins. Furthermore, ablation of other targets such as the subthalamic nucleus and the internal globus pallidus has preliminary shown to safely provide benefit on all Parkinson’s disease motor features and complications. MRgFUS has also been applied, with initial but promising results, in dystonia or obsessive-compulsive disorder, and has started to experimentally be considered in other neurological conditions like refractory epilepsy or stroke. While the main objective of the mentioned applications is the symptomatic relief, the ability of FUS to transiently and focally open the Blood-Brain Barrier through a physical mechanism, have paved the way to impact on the neurodegenerative process and achieve a disease modifying effect. Accordingly, experimental trials for Parkinson’s disease, Alzheimer dementia and amyotrophic lateral sclerosis are ongoing. This talk will present an overview of the current evidence with focused ultrasound in Neurology, with special attention in movement disorders, the most investigated field so far. AWARDS SESSION FRY / LIZZI / PIONEER FRY AWARD, INVITED TALK: Towards an increased clinical impact of focused ultrasound ‐ Chrit Moonen LIZZI AWARD, INVITED TALKS: Exploding droplets and singing bubbles in therapeutic ultrasound ‐ Kevin Haworth A healthy future for focal conformal therapeutic ultrasound ‐ W. Apoutou N’Djin PIONEER AWARD: Presentation of the ISTU/EUFUS Pioneer Award winner, Leonid Gavrilov TOWARDS AN INCREASED CLINICAL IMPACT OF FOCUSED ULTRASOUND Chrit Moonen Imaging Division, University Medical Center, The Netherlands E-mail [email protected] HIFU is a disruptive, minimally invasive, therapeutic technology in medicine, and its history follows the nature cycle from the inventive stage, technical developments, preclinical and clinical applications. Following early promise by the Fry brothers, the advent of image guidance and many technical refinements, clinical applications started with prostate cancer, and have since broadened considerably to other tumors, and include not only tissue ablation but also drug delivery and immune system stimulation. The current status and progress is well described by the FUSFoundation annual reports. Although HIFU fits well in current strategies of personalized and precision medicine, of patient Quality-of-Life, clinical adoption of HIFU is slow, and adequate reimbursement is often lacking. Here, the hurdles for further progress are analyzed. A comparison is made between HIFU and recent developments in RadioTherapy. Clinical workflow for HIFU and RadioTherapy are similar, and image guidance has become a major issue for both therapeutic technologies. The importance of moving beyond feasibility studies of HIFU towards randomized, multi-site, clinical trials is highlighted. Financial issues play an important role since the business model for companies working in HIFU is very different from that in Pharma, and Radio Therapy, and it is hard to find financial support for such Phase 3 trials. For hospitals, HIFU equipment is an additional investment, not replacing other modalities. Sufficient patient numbers have to be treated to guarantee a return on investment. In addition, since HIFU is a disruptive technology, FDA approval based on 510k clearance, is not possible and hence, regulatory issues are more difficult for HIFU than for RadioTherapy. Nevertheless, recent highlights in the treatment of essential tremor, its increasing share in prostate cancer therapy and in uterine fibroid treatment, show that it is possible to increase the clinical impact of HIFU. As patient awareness of HIFU is increasing, HIFU is finding its way into the clinic. EXPLODING DROPLETS AND SINGING BUBBLES IN THERAPEUTIC ULTRASOUND K. J. Haworth1,2 1 Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA 2 Department of Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio, USA e-mail: [email protected] Though widely used clinically for diagnostic imaging, microbubbles also provide a rich opportunity for inducing bioeffects, both intended and unintended. Phase-change agents that take advantage of acoustic droplet vaporization are particularly interesting for therapeutic applications due to their in situ ultrasound-mediated production of microbubbles. The first half of this presentation will provide a review of these applications (with a focus on the author’s humble contributions to the field), including a new subfield of localized dissolved gas scavenging. In addition to the direct mediation of therapies, the microbubbles can also be used to improve both therapeutic insonation focusing and image-guidance. Using microbubble scattering and emissions for guiding therapy will be reviewed in the second half of this presentation. In particular, passive cavitation imaging will be reviewed, including methods, applications, limitations, and future directions. A HEALTHY FUTURE FOR FOCAL CONFORMAL THERAPEUTIC ULTRASOUND W.A. N’Djin1 1 LabTAU, INSERM, Centre Léon Bérard, Université Lyon 1, Univ Lyon, F-69003, Lyon, France e-mail: [email protected] Therapeutic ultrasound is in constant evolution. Focal/conformal strategies are now often sought after to improve the patient care, but their development remains challenging and requires bringing together new solutions. In open surgery, we proposed an unconventional toroidal focusing strategy for USgHIFU therapy of liver metastases. This solution allowed optimizing the energy distribution, to generate and juxtapose manually large ablations, little affected by vascularization and organ motions. A clinical study ran in France validated the concept of complementary tool
Load more

Recommended publications
  • Cancer Care Who Is a Candidate?
    INFUSIO TREATMENT PROGRAMS CANCER CARE WHO IS A CANDIDATE? Foundational Medicine and Infusio’s Integrative Treatment approach may help curb cancer growth, and rejuvenate a depleted body, thereby activating the healing process in various forms of cancer such as: • Bladder cancer • Bone cancer • Breast cancer • Cervical cancer • Colon cancer • Gallbladder cancer • Intestinal cancer • Liver cancer • Lung cancer • Melanoma • Ovarian cancer • Pancreatic cancer • Prostate cancer • Soft tissue sarcoma • Stomach cancer • Squamous cell carcinoma • Testicular cancer • Thyroid cancer CANCER CARE: THE INFUSIO APPROACH Cancer is a life-changing disease. Hearing the words “you have cancer” can be overwhelming and trigger feelings of hopelessness. Processing the initial flood of information, as well as making an informed choice about your therapy options can be challenging. But rest assured, cancer can be overcome. Not all patients wish to undergo chemotherapy or radiation. Others look to augment their cancer protocol with science-based therapies and alternative treatments. Finding a reliable partner is an important step in building an individualized treatment path you feel comfortable with. Infusio offers a range of integrative options for dealing with cancer that work. We use a balanced approach to cancer therapies. Not all standard treatments are bad, and not all alternative treatments are good. In fact, we believe it is important to incorporate the best of each approach into an integrative therapy. Infusio practices integrative medicine, using foundational, non-toxic and minimally invasive methods, combining the best of cutting-edge science and technology with natural medicine. Our team of doctors, naturopaths, nurses and physiotherapists are ready for the challenge of helping you to achieve greater health and healing.
    [Show full text]
  • ELECTION RESULTS Primary Election Aug
    50¢ Friday/ Saturday August 21-22, 2020 www.perrynewspapers.com Reboots and Recounts Primary election winners announced at 5 a.m. after delays caused by technical issues and human error What started out as a Moody and Circuit Judge relatively normal election Greg Parker. The ballot night Tuesday turned out was one of a number of to be anything but, leaving irregularities they had to local candidates waiting contend with following the hours for the final unofficial voting deadline. The board results as elections staff ultimately decided to accept working into the early- the ballot, but rejected morning hours. several others (see related According to Supervisor story). of Elections Dana Once the deadline passed, Southerland, the problems Southerland collected the began with a memory last few ballots that had been card failure, but that was deposited in the drop box, compounded by human adding them to the others error as she and her staff that had been delivered hastily attempted to since the canvassing last overcome the original issue. met earlier in the day. Ultimately, it wasn’t until Then, with the canvassing around 5 a.m. Wednesday board watching, three staff – some 10 hours after polls members worked to open closed Tuesday evening -- the envelopes and stack the that the final 2,300 mail-in ballots. The 108 envelopes ballots were added to the produced 107 ballots, vote totals. Election officials and members of the Canvassing Board found themselves sorting more than because one turned out to In the waning minutes 2,000 ballots by hand just before the clock struck midnight Tuesday.
    [Show full text]
  • Statistical Analysis Plan
    Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This
    [Show full text]
  • Hyperthermia with Radiation Therapy for Chest Wall Recurrences
    JN053_Jrnl_50305McCor.qxd 3/6/07 1:46 AM Page 345 345 Original Article Counterpoint: Hyperthermia with Radiation Therapy for Chest Wall Recurrences Beryl McCormick, MD, New York, New York Key Words The synergy between HT and RT effects on malig- Breast cancer, chest wall recurrence, hyperthermia, radiation therapy nant tissues has been recognized for more than 80 years. Perez et al.1 note a report published in 1935 by Warren,2 Abstract combining heat and x-ray therapy. They also describe the The 2007 National Comprehensive Cancer Network Breast Cancer excitement about combining HT and RT that began in Clinical Practice Guidelines in Oncology include a consideration for the 1970s but add in the 1987 edition of this classic RT hyperthermia (HT) and radiation for women with recurrent locore- textbook that, “the clinical use of heat has been ham- gional advanced breast cancers after first-line surgery or radiation failed. Although HT in this setting has been used for several decades, pered by a lack of adequate equipment to deliver effec- recent reports are few. This article reviews the data from several re- tive heat in deep-seated lesions and of thermometry cent studies, selected because they included at least 100 patients. techniques that provide reliable information on heat dis- Unresolved issues of radiation dose, optimal temperature and tim- tribution in target tissues.”1 ing of HT, and quality assurance problems with thermometry are A recent review article on HT almost 2 decades later apparent from these studies. Although clearly an effective treat- states that, “to reach temperatures clearly above the sys- ment option in this clinical scenario, more research on HT and radi- ation is needed before this treatment combination can be considered temic temperature of 37.5°C in a defined target is a tech- 3 standard care.
    [Show full text]
  • Phase Compensation Technique for Effective Heat Focusing in Microwave Hyperthermia Systems
    applied sciences Article Phase Compensation Technique for Effective Heat Focusing in Microwave Hyperthermia Systems Seonho Lim and Young Joong Yoon * The Electrical and Electronic Engineering Department, Yonsei University, Seoul 03772, Korea; [email protected] * Correspondence: [email protected] Abstract: In this paper, effective electromagnetic (EM) focusing achieved with a phase compensation technique for microwave hyperthermia systems is proposed. To treat tumor cells positioned deep inside a human female breast, EM energy must be properly focused on the target area. A circular antenna array for microwave hyperthermia allows EM energy to concentrate on a specific target inside the breast tumor. Depending on the cancerous cell conditions in the breast, the input phases of each antenna are calculated for single and multiple tumor cell locations. In the case of multifocal breast cancer, sub-array beam focusing via the phase compensation technique is presented to enhance the ability of EM energy to concentrate on multiple targets while minimizing damage to normal cells. To demonstrate the thermal treatment effects on single and multiple tumor locations, the accumulation of the specific absorption rate (SAR) parameter and temperature changes were verified using both simulated and experimental results. Keywords: microwave hyperthermia; circular array antenna; phase compensation technique; tumor treatment; electromagnetic beam focusing; female breast phantom Citation: Lim, S.; Yoon, Y.J. Phase Compensation Technique for Effective Heat Focusing in 1. Introduction Microwave Hyperthermia Systems. Breast cancer treatments have been investigated throughout the past decade, and Appl. Sci. 2021, 11, 5972. https:// thermal treatments for breast cancer using microwaves are being rapidly developed to doi.org/10.3390/app11135972 reduce the dangerous side effects associated with conventional methods [1].
    [Show full text]
  • WHOLE BODY HYPERTHERMIA the Development of and Experience with a Clinical Method
    WHOLE BODY HYPERTHERMIA The development of and experience with a clinical method TOTALE LICHAAMSHYPERTHERMIE De ontwikkeling van en ervaring met een klinische methode Proefschrift Ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de Rector Magnificus Prof. Dr. A.H.G. Rinnooy Kan en volgens besluit van het college van dekanen De openbare verdediging zal plaatsvinden op woensdag 8 april 1987 te 15.45 uur door Jacoba van der Zee geboren te Zwartewaal PROMOTIECOMMISSIE Promotoren: Prof.Dr. H.S. Reinhold Prof.Dr. W. Erdmann Overige leden: Prof.Dr. D.W. van Bekkum Prof.Dr. B.H.P. van der Wed-Messing CDNI'ENI'S SECI'ION I INriDDUCI'IONARY Cllapter I INriDDUCI'ION History 9 Obje::tives 12 Cllapter II THERIDBIOI.OGY Thernobiology 15 Tumour physiology under normothermic conditions 18 Hyperthermia effe::ts on turnour physiology 19 Hyperthermia in caribination with radiotherapy 21 Hyperthermia caribined with chem::>therapy 23 Cllapter III TECBNIQUES IN\ULVED IN THE APPLIClfi'ION OF HYPERI'HERMIA Introduction 27 Thernophysiology in man 28 Thermoregulation 29 J?ody temperature 30 Thennanetry 31 Te::hniques for the induction of hyperthermia 35 -Local hyperthermia 35 -Regional hyperthermia 38 -Whole body hyperthermia 39 Review of WEfl.T investigations 43 SECI' ION II INrriAL RESEARCH Cllapter IV IEVEIDPMENI' OF THE .AilM'.I'ED EOMP-SIEMENS CABIN ME:I'HOD History 49 The Porrp Siemens cabin 49 Animal experiments 52 1) Investigation of operational aspe::ts and heating capacity of the cabin and general toxicity of WEHI' in dogs 52 2) M=!asurement of cerebral temperature and epidural pressure during WEfl.T in dogs 63 Temperature measurements in some patients under hyperthennic conditions 69 1) Temperature measurements during c.
    [Show full text]
  • Hyperthermia) Manual for Skin Cancer & Infection
    THERMOTHEROPY (HYPERTHERMIA) MANUAL FOR SKIN CANCER & INFECTION Dr. Rick NEVER USE IT ON 1. INITIAL VENOMOUS & POISONOUS BITES AND STINGS, a. Use Transcutaneous Electrotherapy on Toxic Reactions (THIS INCLUDES VACCINATIONS)! 2. ALLERGIC REACTIONS a. Use DMSO Therapy on Allergies 3. NEUROPATHY (LACK OF SENSATION) a. OK to use temperature-controlled water therapy TABLE OF CONTENTS Click on the link to go to the section. Click on the section title to return to the Table of Contents. • Like all of our treatments, it is not necessary to understand how the procedure works. Just like it’s not essential to know how a car works. • However, you must know how to do the treatments, just like you need to know how to drive a car. Links are underlined; click on them to learn more. • INTRODUCTION • HOW THERMOTHERAPY WORKS • CONTRAINDICATIONS - DO NOT USE ON • WHAT IT WORKS ON • WHAT YOU WILL NEED • HOW TO DO THERMOTHERAPY o HOT AIR THERAPY FOR SKIN ISSUES o HOT WATER THERAPY FOR SKIN ISSUES ▪ HOT WATER THERAPY FOR ABSCESSED TEETH • THERMOTHERAPY FOR OTHER CANCERS AND METASTATIC SKIN CANCERS • THERMOTHERAPY REFERENCE ARTICLES INTRODUCTION • Like all of our treatments, it is not necessary to understand how the procedure works. Just like it’s not essential to know how a car works. • However, you must know how to do the treatments, just like you need to know how to drive a car. • THIS COURSE, LIKE ALL OF OUR COURSES, IS A READER TESTED COURSE. o Reader tested means that we accept and encourage the readers to let me know if they: ▪ Find any errors, ▪ If it does not work for you for a particular problem (let us know what the problem is), ▪ If you modify a course protocol and it does a better job, please click HERE to email an editor at the Truth, Hope, Love University.
    [Show full text]
  • Synthesis, Physical Characterization, Antifungal and Antibacterial Activity of Oleic Acid-Capped Nanomagnetite and Cobalt-Doped Nanomagnetite
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Scholarship at UWindsor University of Windsor Scholarship at UWindsor Chemistry and Biochemistry Publications Department of Chemistry and Biochemistry 2019 Synthesis, physical characterization, antifungal and antibacterial activity of oleic acid-capped nanomagnetite and cobalt-doped nanomagnetite Abbas Rahdar Department of Physics, University of Zabol Hamid Beyzaei Department of Chemistry, University of Zabol Mohsen Saadat Department of Physics, University of Sistan and Baluchestan Xiao Yu Department of Chemistry and Biochemistry, University of Windsor John F. Trant Department of Chemistry and Biochemistry, University of Windsor Follow this and additional works at: https://scholar.uwindsor.ca/chemistrybiochemistrypub Part of the Biochemistry, Biophysics, and Structural Biology Commons, and the Chemistry Commons Recommended Citation Rahdar, Abbas; Beyzaei, Hamid; Saadat, Mohsen; Yu, Xiao; and Trant, John F.. (2019). Synthesis, physical characterization, antifungal and antibacterial activity of oleic acid-capped nanomagnetite and cobalt- doped nanomagnetite. Canadian Journal of Chemistry. https://scholar.uwindsor.ca/chemistrybiochemistrypub/141 This Article is brought to you for free and open access by the Department of Chemistry and Biochemistry at Scholarship at UWindsor. It has been accepted for inclusion in Chemistry and Biochemistry Publications by an authorized administrator of Scholarship at UWindsor. For more information, please contact [email protected]. Notice: This is the peer reviewed version of an article that will be published in an upcoming issue of the Canadian Journal of Chemistry. This accepted manuscript is published in advance of the final version, and upon acceptance of the manuscript. 1 1 Synthesis, physical characterization, antifungal and antibacterial 2 activity of oleic acid-capped nanomagnetite and cobalt-doped 3 nanomagnetite 4 Abbas Rahdar1*, Hamid Beyzaei2, Mohsen Saadat3, Xiao Yu4, John F.
    [Show full text]
  • Status Quo and Directions in Deep Head and Neck Hyperthermia Margarethus M
    Paulides et al. Radiation Oncology (2016) 11:21 DOI 10.1186/s13014-016-0588-8 REVIEW Open Access Status quo and directions in deep head and neck hyperthermia Margarethus M. Paulides* , Gerda M. Verduijn and Netteke Van Holthe Abstract The benefit of hyperthermia as a potent modifier of radiotherapy has been well established and more recently also the combination with chemotherapy was shown beneficial. Also for head and neck cancer, the impact of hyperthermia has been clinically demonstrated by a number of clinical trials. Unfortunately, the technology applied in these studies provided only limited thermal dose control, and the devices used only allowed treatment of target regions close to the skin. Over the last decade, we developed the technology for deep and controlled hyperthermia that allows treatment of the entire head and neck region. Our strategy involves focused microwave heating combined with 3D patient-specific electromagnetic and thermal simulations for conformal, reproducible and adaptive hyperthermia application. Validation of our strategy has been performed by 3D thermal dose assessment based on invasively placed temperature sensors combined with the 3D patient specific simulations. In this paper, we review the phase III clinical evidence for hyperthermia in head and neck tumors, as well as the heating and dosimetry technology applied in these studies. Next, we describe the development, clinical implementation and validation of 3D guided deep hyperthermia with the HYPERcollar, and its second generation, i.e. the HYPERcollar3D. Lastly, we discuss early clinical results and provide an outlook for this technology. Keywords: Head and neck cancer, Radiofrequency, Hyperthermia, Electromagnetic modelling, Thermal therapy Introduction multimodality treatment [7].
    [Show full text]
  • 2006Football.Pdf
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
    [Show full text]
  • 2017-18 JMU Men's Basketball
    2017-18 JMU MEN’S BASKETBALL Table of Contents Roster ..................................................................2 Schedule ..............................................................3 Quick Facts .........................................................4 Head Coach Louis Rowe ..................................5 Coaching Staff ...................................................6 Support Staff ......................................................7 Players ..........................................................8-10 2016-17 Box Scores ...............................11-18 2016-17 Season Stats ...........................19-21 Season-by-Season Stats ..............................22 Record Book Individual Records .........................................23 Team Records .................................................24 Single-Game Leaders ....................................25 Opponent Records .........................................25 Convocation Center Records .......................26 Records by Class .............................................27 Top Performances ..........................................28 Top-10 Lists .............................................29-30 Awards/Honors ...............................................31 Year-by-Year Leaders ............................ 32-33 All-Time Results ......................................34-40 All-Time Series Records ................................41 All-Time Results by DI Opponents .......42-47 All-Time Jersey Numbers .............................48 All-Time Letterwinners
    [Show full text]
  • Hyperthermia
    review Article Oman Medical Journal [2016], Vol. 31, No. 2: 89–97 Hyperthermia: How Can It Be Used? Zhaleh Behrouzkia 1, Zahra Joveini2*, Behnaz Keshavarzi2, Nazila Eyvazzadeh3 and Reza Zohdi Aghdam4 1Medical Physics Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran 2Student Research Committee, Urmia University of Medical Science, Urmia, Iran 3Radiation Research Center, Faculty of Paramedicine, AJA University of Medical Sciences, Tehran, Iran 4Medical Physics Department, Faculty of ParaMedicine, Urmia University of Medical Sciences, Urmia, Iran ARTICLE INFO ABSTRACT Article history: Hyperthermia (HT) is a method used to treat tumors by increasing the temperature of the Received: 27 December 2015 cells. The treatment can be applied in combination with other verified cancer treatments Accepted: 25 January 2016 using several different procedures. We sought to present an overview of the different HT Online: tumor treatment, recent advances in the field, and combinational treatment sequences DOI 10.5001/omj.2016.19 and outcomes. We used a computer-aided search to identify articles that contained the keywords hyperthermia, cancer treatment, chemotherapy, radiotherapy, nanoparticle, and Keywords: Hyperthermia; Cancer cisplatin. There are three types of HT treatment, which each need the use of applicators Treatment Protocols; that are in contact with or in the proximity of the patient for the purpose of heating. Chemotherapy; Radiotherapy. Heating can be achieved using different types of energy (including microwaves, radio waves, and ultrasound). However, the source of energy will depend on the cancer type and location. The temperature used will also vary. HT is rarely used alone, and can be combined with other cancer treatments.
    [Show full text]